BML Investment Partners, L.P. 13D and 13G filings for Oramed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 4:41 pm Purchase |
2024-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP |
BML Investment Partners, L.P. | 2,643,907 6.550% |
595,273 (+29.06%) |
Filing |
| 2024-09-16 4:42 pm Purchase |
2024-09-10 | 13G | Oramed Pharmaceuticals Inc. ORMP |
BML Investment Partners, L.P. | 2,048,634 5.000% |
2,048,634 (New Position) |
Filing |